[1] |
Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature[J]. Am J Surg Pathol, 2005,29(12):1558⁃1575. doi: 10.1097/01.pas.0000173232.22117.37.
|
[2] |
Llamas⁃Velasco M, Requena L, Mentzel T. Cutaneous perivascular epithelioid cell tumors: a review on an infrequent neoplasm[J]. World J Methodol, 2016,6(1):87⁃92. doi: 10.5662/wjm.v6.i1.87.
|
[3] |
Liegl B, Hornick JL, Fletcher CD. Primary cutaneous PEComa: distinctive clear cell lesions of skin[J]. Am J Surg Pathol, 2008,32(4):608⁃614. doi: 10.1097/PAS.0b013e31815604ab.
|
[4] |
Haiges D, Kurz P, Laaff H, et al. Malignant PEComa[J]. J Cutan Pathol, 2018,45(1):84⁃89. doi: 10.1111/cup.13061.
|
[5] |
Charli⁃Joseph Y, Saggini A, Vemula S, et al. Primary cutaneous perivascular epithelioid cell tumor: a clinicopathological and molecular reappraisal[J]. J Am Acad Dermatol, 2014,71(6):1127⁃1136. doi: 10.1016/j.jaad.2014.08.016.
|
[6] |
Ueberschaar S, Goebeler M, Kneitz H. CD10⁃positive cutaneous PEComa: an extremely rare skin tumour[J]. Case Rep Dermatol, 2020,12(3):192⁃198. doi: 10.1159/000510718.
|
[7] |
Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family[J]. Ann Diagn Pathol, 2015,19(5):359⁃368. doi: 10.1016/j.anndiagpath.2015.06.003.
|
[8] |
Kenerson H, Folpe AL, Takayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms[J]. Hum Pathol, 2007,38(9):1361⁃1371. doi: 10.1016/j.humpath.2007.01.028.
|
[9] |
Schoolmeester JK, Dao LN, Sukov WR, et al. TFE3 translocation⁃associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis[J]. Am J Surg Pathol, 2015,39(3):394⁃404. doi: 10. 1097/PAS.0000000000000349.
|